Human Leukocyte Antigens Class II Alleles Affecting the Response to 5–7 Year Antiretroviral Therapy in A Latvian Cohort

Anonymous (2016a). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. 2^nd edn. World Health Organization, Geneva. Available from: http://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf?sequence=1 (accessed 14 September 2018).Search in Google Scholar

Anonymous (2016b). QIAamp DNA Mini and Blood Mini Handbook. QIAGEN. Sample & Assay Technologies, 5^th edn. Available from: https://www.qiagen.com/jp/resources/download.aspx?id=62a200d6-faf4-469b-b50f-2b59cf738962&lang=e (accessed 12 April 2018).Search in Google Scholar

Anonymous (2018). HLA-DRB1, DQ1, DQB1 REAL-TIME PCR Genotyping Kits. DNA-Technology. Available from: http://www.dna-technology.ru/eng/dnaproducts/reagents/ (accessed 12 April 2018).Search in Google Scholar

Balandraud, N., Picard, C., Reviron, D., Landais, C., Toussirot, E., Lambert, N., Telle, E., Charpin, C., Wendling, D., Pardoux, E., Auger, I., Roudier, J. (2013). HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis. PLoS ONE, 8 (5), e64108.10.1371/journal.pone.0064108366784323737967Search in Google Scholar

Boettiger, D.C., Kerr, S., Ditangco, R., Merati, T. P., Pham, T. T. T., Chaiwarith, R., Kiertiburanaku, S., Li, C. K. P., Kumarasamy, N., Vonthanak, S., Lee C., Kinh, N. V., Pujari, S., Wong, W. W., Kamarulzaman, A., Zhang, F., Yunihastuti, E., Choi, J. Y., Oka, S., Ng, O. T., Kantipong P., Mustafa, M., Ratanasuwan, W., Sohn, A., Law, M. (2014). Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database. PLoS ONE, 9 (9), e106525.10.1371/journal.pone.0106525415361125184314Search in Google Scholar

Buck, D., Cepok, S., Hoffmann, S., Grummel, V., Jochim, A., Berthele, A., Hartung, H.-P., Wassmuth, R., Hemmer, B. (2011). Influence of the HLA-DRB1 genotype on antibody development to Interferon Beta in multiple sclerosis. Arch. Neurol., 68 (4), 480–487.10.1001/archneurol.2011.6521482927Search in Google Scholar

Gezie, L. D., Gelaye, K. A., Worku, A. G., Ayele, T. A., Teshome, D. F. (2017). Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia. BMC Res Notes, 10, 277.10.1186/s13104-017-2602-0551298128705176Search in Google Scholar

Goronzy, J. J., Matteson, E. L., Fulbright, J. W., Kenneth J. Warrington, K. J., Chang-Miller, A., Hunder, G. G., Mason, T. G., Nelson, A. M., Valente, R. M., Crowson, C. S., Erlich, H. A., Reynolds, R. L., Swee, R. G., O’Fallon, W. M., Weyan, C. M. (2004). Prognostic markers of radio-graphic progression in early rheumatoid arthritis. Arthritis Rheum., 50 (1), 43–54.10.1002/art.1144514730598Search in Google Scholar

Haas, D. W., Smeaton, L. M., Shafer, R. W., Robbins, G. K., Morse, G. D., Labbe, L., Wilkinson, G. R., Clifford, D. B., D’Aquila R. T., De Gruttola, V., Pollard, R. B., Merigan, T. C., Hirsch, M. S., George, A. L., Donahue, J. P., Kim, R. B. (2005). Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: An adult aids clinical trials group study. J. Infect. Dis., 192, 1931–1942.10.1086/49761016267764Search in Google Scholar

Julg, B., Moodley, E. S., Qi, Y., Ramduth, D., Reddy, S., Mncube, Z., Gao, X., Goulder, P. J., Detels, R., Ndung’u, T., Walker, B. D., Carrington, M. (2011). Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. J. Infect. Dis., 203, 803–809.10.1093/infdis/jiq122307113121257739Search in Google Scholar

Kapitány, A., Szabó, Z., Lakos, G., Aleksza, M., Végvári, A., Soós, L., Karányi, Z., Sipka, S., Szegedi, G., Szekanecz, Z. (2008). Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. Israel Med. Assoc. J, 10, 32–36.Search in Google Scholar

Keet, I. P. M., Tang, J., Klein, M. R., LeBlanc, S., Enger, C., Rivers, C., Apple R. J., Mann, D., Goedert, J. J., Miedema, F., Kaslow, R. A. (1999). Consistent association of HLA Class I and II and transporter gene products with progression of human immunodeficiency Virus Type 1 infection in homosexual men. J. Infect. Dis., 180, 299–309.10.1086/31486210395843Search in Google Scholar

Keiser, O., MacPhail, P., Boulle, A., Wood, R., Schechter, M., Dabis, F., Sprinz, E., Egger, M., for the ART-LINC Collaboration of the international databases to evaluate AIDS (IeDEA) (2009). Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy. Trop. Med. Int. Health, 14 (10), 1220–1225.10.1111/j.1365-3156.2009.02338.x372249719624478Search in Google Scholar

Langford, S. E., Ananworanich, J., Cooper, D. A. (2007). Predictors of disease progression in HIV infection: A review. AIDS Res. Ther., 4, 11.10.1186/1742-6405-4-11188753917502001Search in Google Scholar

Lucas, G. M., Chaisson, R. E., Moore, R. D. (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann. Intern. Med., 131, 81–87.10.7326/0003-4819-131-2-199907200-00002Search in Google Scholar

Lundgren, J. D., Mocroft, A., Gatell, J. M., Ledergerber, B., Monforte, A., Hermans, F., Goebel, F.-D., Blaxhult, A., Kirk, O., Phillips, A. N., for the EuroSIDA Study Group (2002). A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: Results from the EuroSIDA study. J. Infect. Dis., 185, 178–187.10.1086/338267Search in Google Scholar

Malhotra, U., Holte, S., Dutta, S., Berrey, M. M., Delpit, E., Koelle, D. M., Sette, A., Corey, L., McElrath, M. J. (2001). Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J. Clin. Invest., 107, 505–517.10.1172/JCI11275Search in Google Scholar

Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A. M., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., James, I., Christiansen, F. T. (2002). Association between the presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet, 359, 727–732.10.1016/S0140-6736(02)07873-XSearch in Google Scholar

Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., Phair, J. P., Rinaldo, C. P. (1997). Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med., 126 (12), 946–954.10.7326/0003-4819-126-12-199706150-000039182471Search in Google Scholar

Montarroyos, R. U., Miranda-Filho, C. D., César, C. C., Souza, W. V., Lacerda, H. R., Albuquerque, M. F. P. M., Aguiar, M. F., Ximenes, R. A. A. (2014). Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: A multilevel analysis. PLoS ONE, 9 (2), e84276.10.1371/journal.pone.0084276391478524505247Search in Google Scholar

Odafe, S., Torpey, K., Khamofu, H., Ogbanufe, O., Oladele, E. A., Kuti, O., Adedokun, O., Badru, T., Okechukwu, E., Chabikuli, O. (2012). The Pattern of Attrition from an Antiretroviral Treatment Program in Nigeria. PLoS ONE, 7 (12), e51254.10.1371/journal.pone.0051254352176223272094Search in Google Scholar

Pantaleo, G., Fauci, A. S. (1996). Immunopathogenesis of HIV infection. Annu. Rev. Microbiol., 50 (1), 825–854.10.1146/annurev.micro.50.1.8258905100Search in Google Scholar

Patrikar, S., Shankar, S., Kotwal, A., Basannard, D. R., Bhattie, V., Vermaf, R., Mukherj, S. (2017). Predictors of first line antiretroviral therapy failure and burden of second line antiretroviral therapy. Med. J. Armed Forces India, 73, 5–11.10.1016/j.mjafi.2016.09.008522136028123238Search in Google Scholar

Pavlos, R., Mallal, S., Phillips, E. (2012). HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 13 (11), 1285–1306.10.2217/pgs.12.10822920398Search in Google Scholar

Ranasinghe, S., Cutler, S., Davis, I., Lu, R., Soghoian, D. Z., Qi, Y., Sidney, J., Kranias, G., Flanders, M. D., Lindqvist, M., Kuhl, B., Alter, G., Deeks, S. G., Walker, B. D., Gao, X., Sette, A., Carrington, M., Streeck, H. (2013). Association of HLA-DRB1–restricted CD4+ T cell responses with HIV immune control. Nat. Med., 19, 930–933.10.1038/nm.3229397440823793098Search in Google Scholar

Robbins, G. K., Daniels, B., Zheng, H., Chueh, H., Meigs, J. B., Freedberg, K. A. (2007). Predictors of antiretroviral treatment failure in an urban HIV clinic. J. Acquir. Immune Def. Syndr., 44, 30–37.10.1097/01.qai.0000248351.10383.b7236574517106280Search in Google Scholar

Saah, A. J., Hoover, D. R., Weng, S., Carrington, M., Mellors, J., Rinaldo, C. R., Mann, D., Apple, R., Phair, J. P., Detels, R., O’Brien, S., Enger, C., Johnson, P., Kaslow, R. A., Multicenter AIDS Cohort Study. (1998). Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. AIDS, 12 (16), 2107–2113.10.1097/00002030-199816000-000059833851Search in Google Scholar

Zanelli, E., Breedveld, F. C., de Vries, R. R. P. (2002). HLA association with autoimmune disease: A failure to protect? Rheumatology, 39, 1060–1066.10.1093/rheumatology/39.10.106011035123Search in Google Scholar

Zhu, P., Zhu, Q., Zhang, Y., Ma, X., Li, Z., Li, J., Chen, J., Luo, L., Ring, H. Z., Ring, R. Z., Su, L. (2013). ABCB1 variation and treatment response in AIDS patients: Initial results of the Henan Cohort. PLoS ONE, 8 (1), e55197.10.1371/journal.pone.0055197355587923372834Search in Google Scholar